Cardiovascular · De Novo · 2018

Acumen Hypotension Prediction Index (HPI) Feature Software

Edwards Lifesciences LLC. Granted by FDA on 16 March 2018 under submission DEN160044, product code QAQ (adjunctive predictive cardiovascular indicator). What FDA's record says, in FDA's words.

Device record · DEN160044

  1. Device. Acumen Hypotension Prediction Index (HPI) Feature SoftwareDEVICE
  2. Company. Edwards Lifesciences LLCCOMPANY
  3. Decision. 16 March 2018, De NovoDECISION
  4. Panel. CardiovascularPANEL
  5. Product code. QAQ, Adjunctive Predictive Cardiovascular IndicatorCODE
  6. Regulation. 21 CFR 870.2210, Class IIREG
  7. Source. FDA database entry · decision document (14 pages)SOURCE

Retrieved · the fields above are FDA's; the statement below was copied from the decision document on that day.

What FDA granted it for

The Indications for Use statement could not be read from a public decision document for this submission on the retrieval date (the document is absent, scanned without text, or filed under another number). FDA's database entry is the place to read it.

The product code's definition, from FDA's classification record. The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Adverse-event reports in MAUDE, by product code

As of , MAUDE held 31 reports filed against devices carrying product code QAQ. That code is shared by every device of this type, not this device alone, and MAUDE reports are submitted by manufacturers, facilities and the public without FDA verification. The latest reports, in the reporter’s words:

14 January 2026 · Injury · HEMOSPHERE · EDWARDS LIFESCIENCES · report 2015691-2026-10408

AS REPORTED, DURING USE IN PATIENT, A HEMOSPHERE MONITOR WAS ON DEMO MODE FOR A NIGHT WITH A FLOTRAC SENSOR AND OXIMETRY CATHETER. ALTHOUGH "DEMO MODE" WAS DISPLAYED ON THE MONITOR, THE PHYSICIAN WHO PERFORMED CALIBRATION DID NOT REALIZE THAT IT WAS DEMO MODE. ON THE NEXT MORNING, THE NURSE NOTICED IT WAS DEMO MODE AS THE WAVEFORM DID NOT BECOME FLAT BY OPENING THE VENT PORT TO THE ATMOSPHERE WHEN ATTEMPTED TO ZERO THE FLOTRAC SENSOR. THE BLOOD PRESSURE WAVEFORM HAD BEEN MONITORED CORRECTLY […]

18 November 2025 · Malfunction · HEMOSPHERE ALTA · EDWARDS LIFESCIENCES · report 2015691-2025-09384

IT WAS REPORTED THAT, DURING USE, THE BLOOD PRESSURE (BP) READINGS OBTAINED FROM AN ALTA MONITOR WAS SIGNIFICANTLY INCONSISTENT AND NOT CORRELATING WITH THE NON-INVASIVE BLOOD PRESSURE CUFF OR INVASIVE ARTERIAL LINE. MEAN ARTERIAL PRESSURE (MAP) VALUES, SYSTOLIC, AND DIASTOLIC VALUES WERE OFTEN VASTLY INACCURATE, EITHER MUCH HIGHER OR LOWER. PER REPRESENTATIVE, "THIS DISCREPANCY APPEARS TO RESOLVE ONLY WHEN THE PATIENT MONITOR IS ZEROED BEFORE ACUMEN IQ FINGER CUFF APPLICATION." THE FOLLOWING […]

18 November 2025 · Malfunction · HEMOSPHERE ALTA · EDWARDS LIFESCIENCES · report 2015691-2025-09385

IT WAS REPORTED THAT, DURING USE, THE CARDIAC OUTPUT AND CARDIAC INDEX WAS INCORRECT ON THE HEMOPSHERE ALTA ALL 1 MONITOR. THE CABLE WAS CHANGED OUT BUT THE ISSUE CONTINUED. THE PHYSICIAN LOST CONFIDENCE IN THIS PARTICULAR MONITOR. IT WAS CONFIRMED THAT THERE WAS NO PATIENT INJURY OR HARM ASSOCIATED WITH THE REPORTED ISSUE.

18 November 2025 · Malfunction · HEMOSPHERE ALTA · EDWARDS LIFESCIENCES · report 2015691-2025-09382

IT WAS REPORTED THAT, DURING USE, THE BLOOD PRESSURE (BP) READINGS OBTAINED FROM AN ALTA MONITOR WERE INCONSISTENT AND NOT CORRELATING WITH THE NON-INVASIVE BLOOD PRESSURE CUFF OR INVASIVE ARTERIAL LINE. MEAN ARTERIAL PRESSURE (MAP) VALUES, SYSTOLIC, AND DIASTOLIC VALUES WERE OFTEN VASTLY INACCURATE, EITHER MUCH HIGHER OR LOWER. PER REPRESENTATIVE, "THIS DISCREPANCY HAS OCCURRED REPEATEDLY SEVERAL TIMES PER DAY ACROSS MULTIPLE CASES AND APPEARS TO RESOLVE ONLY WHEN THE PATIENT MONITOR IS […]

25 September 2025 · Malfunction · HEMOSPHERE · EDWARDS LIFESCIENCES · report 2015691-2025-07892

AS REPORTED, DURING USE IN PATIENT, A HEMOSPHERE MONITOR DISPLAYED INACCURATE CENTRAL VENOUS PRESSURE (CVP) VALUES WHILE CONNECTED TO A NIHON-KODEN PATIENT MONITOR VIA AN ANALOG PORT. WHEN VOLTAGE RANGE WAS SET TO 0-1 VOLTS, CVP WAS DISPLAYED AS OUT OF RANGE (-). WHEN VOLTAGE RANGE WAS CHANGED TO 0-5 OR 0-10 VOLTS, CVP WAS DISPLAYED AS 0 MMHG. CVP WAS ALSO SHOWN AS 0 MMHG WHEN THE ANALOG CABLE WAS CONNECTED TO ONLY THE HEMOSPHERE MONITOR WITHOUT CONNECTING TO THE PATIENT MONITOR. THE EXPECTED […]

Where this fits

This page is a record, not medical advice and not a safety rating. It copies FDA's fields and FDA's statement, and lists what the statement's text mentions. Read the labeling before relying on any of it.

More devices under product code QAQ, in Cardiovascular, from Edwards Lifesciences LLC, or granted in 2018. The whole record is at FDA AI-enabled medical devices.

A device's authorized use is a sentence the record can be read against. What Apodicta does on a medical record is that reading: every line of a note, a claim or a report proved to its source or held, before it renders.

Show me on one of my files →

This device is authorized for a stated use. See a record read against what it must prove, on your own file.

Show me on my files